Phathom Pharmaceuticals initiated at Cantor Fitzgerald on ‘significant’ upside
Cantor Fitzgerald initiated coverage of Phathom Pharmaceuticals (PHAT) with an Overweight rating and $23 price target The firm cited ...
Cantor Fitzgerald cuts Informatica price target to $18 from $29
Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
Cantor Fitzgerald maintains $118 target on Ultragenyx stock
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...
Aurora Innovation (AUR) Receives a Hold from Evercore ISI
In a report released yesterday, Chris McNally from Evercore ISI maintained a Hold rating on Aurora Innovation (AUR – Research Report), with a ...
Q4 2024 GoDaddy Inc Earnings Call
Welcome to GoDaddy's fourth quarter and full year 2024 earnings call. Thank you for joining us. I'm Christie Masoner, VP of Investor Relations, and with me today are Aman Bhutani, Chief Executive ...